Table I.
Baseline characteristics of AD/IMH/PAU patients and population referents
| Referents (n=399) | AD/IMH/PAU (n=133) | p* | AD/IMH/PAU Subtypes | p | |||
|---|---|---|---|---|---|---|---|
| AD (n=77) | IMH (n=21) | PAU (n=35) | |||||
| Age (years), mean (SD) | 71.8 (14.1) | 71.8 (14.1) | 1.0 | 68.9 (15.6) | 73.5 (11.5) | 77.1 (10.0) | .015 |
| Male gender | 228 (57.1%) | 76 (57.1%) | 1.0 | 46 (59.7%) | 11 (52.4%) | 19 (54.3%) | .770 |
| Any prior CV event | 67 (16.8%) | 33 (24.8%) | .040 | 18 (23.4%) | 6 (28.6%) | 9 (25.7%) | .878 |
| Prior MI | 21 (5.3%) | 13 (9.8%) | .066 | 6 (7.8%) | 3 (14.3%) | 4 (11.4%) | .556 |
| Prior HF | 29 (7.3%) | 16 (12.0%) | .087 | 9 (11.7%) | 1 (4.8%) | 6 (17.1%) | .458 |
| Prior stroke | 27 (6.8%) | 11 (8.3%) | .560 | 5 (6.5%) | 4 (19.0%) | 2 (5.7%) | .152 |
| Charlson Comorbidity | 1.7 (2.1) | 2.6 (2.6) | <.001 | 2.1 (2.2) | 2.8 (2.6) | 3.7 (3.2) | .006 |
| Index, mean (SD) | |||||||
| Acuity of presentation† | - | <.001 | |||||
| Acute | - | 79 (59.4%) | 52 (67.5%) | 17 (81.0%) | 10 (28.6%) | ||
| Subacute | - | 4 (3.0%) | 2 (2.6%) | 1 (4.8%) | 1 (2.9%) | ||
| Chronic | - | 3 (2.3%) | 2 (2.6%) | 0 (0%) | 1 (2.9%) | ||
| Unknown | - | 47 (35.3) | 21 (27.3%) | 3 (14.3%) | 23 (65.7%) | ||
| Stanford classification | - | <.001 | |||||
| Type A | - | - | 45 (58.4%) | 5 (23.8%) | - | ||
| Type B | - | - | 32 (41.6%) | 16 (76.2%) | - | ||
| De Bakey classification | |||||||
| Type I | - | - | 24 (31.2%) | - | - | ||
| Type II | - | - | 21 (27.3%) | - | - | ||
| Type IIIa | - | - | 8 (10.4%) | - | - | ||
| Type IIIb | - | - | 24 (31.2%) | - | - | ||
| Anatomic localisation | - | - | |||||
| Thoracic | - | - | - | - | 18 (51.4%) | ||
| Abdominal | - | - | - | - | 17 (48.6%) | ||
*
p-values for comparisons between the AD/IMH/PAU and the referent cohort do not acoount for matching
†
Acute: ≤ 14 days of symptom onset; Subacute: 15–90 days; Chronic: > 90 days